What is the official website of Drug Topics ?

The official website of Drug Topics is http://www.drugtopics.com.

What is Drug Topics's cybersecurity risk score?

Drug Topics has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has Drug Topics experienced?

According to Rankiteo, Drug Topics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Drug Topics been affected by any supply chain cyber incidents ?

According to Rankiteo, Drug Topics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Drug Topics have SOC 2 Type 1 certification ?

According to Rankiteo, Drug Topics is not certified under SOC 2 Type 1.

Does Drug Topics have SOC 2 Type 2 certification ?

According to Rankiteo, Drug Topics does not hold a SOC 2 Type 2 certification.

Does Drug Topics comply with GDPR ?

According to Rankiteo, Drug Topics is not listed as GDPR compliant.

Does Drug Topics have PCI DSS certification ?

According to Rankiteo, Drug Topics does not currently maintain PCI DSS compliance.

Does Drug Topics comply with HIPAA ?

According to Rankiteo, Drug Topics is not compliant with HIPAA regulations.

Does Drug Topics have ISO 27001 certification ?

According to Rankiteo,Drug Topics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Drug Topics operate in ?

Drug Topics operates primarily in the Book and Periodical Publishing industry.

How many employees does Drug Topics have ?

Drug Topics employs approximately 8 people worldwide.

Does Drug Topics own any subsidiaries ?

Drug Topics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Drug Topics have ?

Drug Topics's official LinkedIn profile has approximately 6,948 followers.

What is the NAICS classification code for Drug Topics ?

Drug Topics is classified under the NAICS code 511, which corresponds to Publishing Industries (except Internet).

Does Drug Topics have a Crunchbase profile ?

No, Drug Topics does not have a profile on Crunchbase.

Does Drug Topics have a LinkedIn profile ?

Yes, Drug Topics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/drug-topics.

How many cybersecurity incidents has Drug Topics experienced ?

As of July 8, 2026, Rankiteo reports that Drug Topics has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Drug Topics have ?

Drug Topics has an estimated 5,133 peer or competitor companies worldwide.

What types of cybersecurity incidents has Drug Topics faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Drug Topics

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

Drug Topics Vendor Cyber Rating & Cyber Score

drugtopics.com

Add Your Compliance Badge

Drug Topics is the top-ranked monthly retail pharmacy publication. Since 1857, pharmacist readers have received timely news on all phases of community, retail, and health-system issues and trends affecting the practice of pharmacy. We offer a forum for pharmacists to share practical ideas for better pharmacy management and patient care. We proudly serve 155,000 readers.

Drug Topics A.I CyberSecurity Scoring

Scoring History

Drug Topics

Drug Topics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Drug Topics

Cyber Attack

08/2022

MJH018261022

Drug Topics

Breach

5/2018

PHA323072725

Loading…

A.I.

Drug Topics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Drug Topics

Incidents vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for Drug Topics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Drug Topics in 2026.

Incident Types Drug Topics vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for Drug Topics in 2026.

Incident History - Drug Topics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Drug Topics Subsidiaries

Drug Topics

Book and Periodical Publishing

Website: http://www.drugtopics.com

Company Size: 51-200 employees

MJH Life Sciences®Media Production

Pharmacy TimesBook and Periodical Publishing

Targeted OncologyOnline Audio and Video Media

Ophthalmology TimesMedia Production

Modern RetinaMedia Production

OncLiveBook and Periodical Publishing

Dermatology TimesBook and Periodical Publishing

Pharmaceutical ExecutiveBook and Periodical Publishing

dvm360®Veterinary Services

The Center for BiosimilarsBook and Periodical Publishing

Applied Clinical Trials MagazineBook and Periodical Publishing

NeurologyLiveOnline Audio and Video Media

Pharmacy Benefit Management InstitutePharmaceutical Manufacturing

Association of Cancer Care CentersHospitals and Health Care

Institute for Clinical Immuno-Oncology (ICLIO)Hospitals and Health Care

Nutritional OutlookWellness and Fitness Services

Turbomachinery InternationalBook and Periodical Publishing

Cannabis Science and TechnologyBook and Periodical Publishing

LCGC InternationalBook and Periodical Publishing

Psychiatric TimesMedia Production

Cancer NetworkBook and Periodical Publishing

Urology TimesBook and Periodical Publishing

Pharmaceutical Commerce MagazinePharmaceutical Manufacturing

Pharmaceutical TechnologyBook and Periodical Publishing

Ophthalmology Times EuropeMedia Production

AJMC - The American Journal of Managed CareBook and Periodical Publishing

AJMC: Institute For Value Based MedicineHospitals and Health Care

AJMC: Center on Health Equity & AccessInternet News

HCPLiveMedia Production

Managed Healthcare ExecutiveMedia Production

PER®Education Management

American Journal of Hematology / Oncology®Wellness and Fitness Services

Contagion_LiveBook and Periodical Publishing

Spectroscopy MediaBook and Periodical Publishing

Oncology Nursing NewsBook and Periodical Publishing

Physicians PracticeBook and Periodical Publishing

Medical EconomicsBook and Periodical Publishing

BioPharm InternationalBook and Periodical Publishing

Dental Products ReportBook and Periodical Publishing

Optometry TimesMedia Production

CMINon-profit Organizations

Cannabis Science ConferenceEvents Services

Specialty Pharmacy TimesMedia Production

FormularyWatchBook and Periodical Publishing

Contemporary OB/GYNBook and Periodical Publishing

CURE Media GroupBook and Periodical Publishing

Contemporary PediatricsBook and Periodical Publishing

Cannabis Patient CareBook and Periodical Publishing

MJH Thought LeadersMedia Production

Dental Lab ProductsBook and Periodical Publishing

Medical World NewsBroadcast Media Production and Distribution

Modern HygienistMedia Production

Total PharmacyBook and Periodical Publishing

meetmyMSLHospitals and Health Care

Diagnostic Imaging®Online Audio and Video Media

Pharmacy Times Continuing Education™ (PTCE)Education Administration Programs

Infection Control Today®Online Audio and Video Media

Loading…

Drug Topics Similar Companies

Forbes

forbes.com

Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia, and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services, and technology license agreements. Forbes is an equal opportunity employer.

Loading…

NEWS

Drug Topics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 09, 2025 08:00 AM

Digital Health Center of Excellence

UPDATE: December 9, 2025. FDA Announces a Digital Health Devices Pilot. The FDA announces the “Technology-Enabled Meaningful Patient...

Read Article

December 01, 2025 08:00 AM

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has...

Read Article

November 24, 2025 08:00 AM

AI healthcare booms as drug discovery and precision medicine take leaps forward

Explore the evolving role of AI in the healthcare industry. Learn about the optimistic outlook of industry leaders heading into the rest of...

Read Article

October 15, 2025 07:00 AM

11 Quantum Computing Applications & Examples to Know

From cybersecurity to pharmaceutical research to finance, here are some ways quantum computing facilitates major advancements.

Read Article

October 10, 2025 07:00 AM

FDA announces recall for Johnson & Johnson devices due to cybersecurity risk—customers urged to act

The U.S. Food and Drug Administration (FDA) has announced another new recall for Johnson & Johnson MedTech's Automated Impella Controller...

Read Article

October 01, 2025 07:00 AM

2026's top healthcare and pharma conferences

Each year, the healthcare industry organizes a full slate of events that help executives stay on top of the latest trends and innovations in...

Read Article

September 19, 2025 07:00 AM

Conference Preview: NCPA 2025 Annual Convention & Expo

This year's event, from October 18-21, 2025, will take place in New Orleans, Louisiana, at the Ernest N. Morial Convention Center.

Read Article

August 28, 2025 07:00 AM

The 5 biggest challenges facing retail pharmacy

Retail pharmacy operators face an array of challenges beyond PBM reform, which many observers say remains the single biggest obstacle to...

Read Article

July 25, 2025 07:00 AM

DEA and CMS warn physicians that they are being targeted by scams

The Drug Enforcement Administration and the Centers for Medicare & Medicaid Services tell doctors not to respond to suspicious requests for...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-59705

SUMMARY

mem0's openmemory/api component contains an unauthenticated access vulnerability that allows unauthenticated attackers to read, write, and delete arbitrary user memories by accessing API routers registered without authentication middleware. Attackers can supply arbitrary user_id parameters or directly access memory retrieval endpoints to expose private memory content, or invoke pause endpoints with global_pause=true to cause denial-of-service across all users.

Published

Date2026-07-07

Updated

Date2026-07-07

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-59704

SUMMARY

Cap's GET /api/video/ai endpoint fails to validate user ownership or membership before returning private video AI metadata including titles, summaries, and chapters. Authenticated attackers can supply arbitrary video IDs to read sensitive AI-generated content and trigger unauthorized AI generation that consumes the video owner's credits without consent.

Published

Date2026-07-07

Updated

Date2026-07-07

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-55078

SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Starting in version 2.17.0 and prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, `POST /api/v2/files` converts zip uploads to tar in memory via `CreateTarFromZip`, which enforced a per-entry size limit but no aggregate limit on total decompressed output, writing to an unbounded in-memory buffer. Exploitation requires authenticated file-upload access and the impact is limited to availability (denial of service). The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 adds a metadata preflight check that sums projected entry sizes and a streaming writer that enforces the aggregate limit during decompression. As a workaround, restrict file-upload permissions to trusted users or place a reverse proxy with request-body size limits in front of `coderd`.

Published

Date2026-07-07

Updated

Date2026-07-07

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-55077

SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, the `PUT /api/v2/users/{user}/password` endpoint authorized only `ActionUpdatePersonal` and did not prevent a `user-admin` from resetting an `owner` account's password. It also did not require the current password when an admin reset another user's password. Exploitation requires the privileged `user-admin` role so practical risk is limited to deployments that grant `user-admin` to less trusted operators. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 prevents non-owner users from resetting the password of an account that holds the `owner` role. As a workaround, restrict the `user-admin` role to trusted administrators.

Published

Date2026-07-07

Updated

Date2026-07-07

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-55076

SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, Coder's OIDC callback checked `email_verified` with a direct Go `bool` type assertion. When an IdP returned the claim as a non-boolean (for example the string `"false"`) or omitted it, the assertion failed open and the email was treated as verified. Combined with an unconditional email-based account fallback, this enabled account takeover. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 coerces `email_verified` across bool, string and numeric types (fail-closed) and blocks the email fallback when the matched user already has a different linked IdP subject. As a workaround, ensure the IdP returns `email_verified` as a native JSON boolean. The email-fallback linking issue has no configuration workaround; upgrading is required.

Published

Date2026-07-07

Updated

Date2026-07-07

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…